Biotech Values

[DewDiligence]

Nice try at revising history. The admonition you refer to (#msg-64335495) was not about an authorized generic, but rather about potential FDA approval of Lovenox ANDA’s submitted under Paragraph III that investors would not know about. That hasn’t happened and is probably many years away from happening.